Global phase III trials demonstrate that nerandomilast slowed lung function decline in IPF and PPF, with similar discontinuation rates to placebo
Notified -
Globe Newswire19-05-2025, 23:15
Once a Secret Lab, Mound Story Now Being Told Through 18-02-2023, 00:32